Inventor · disambiguated record
W. Mark Eickhoff
Also filed as: EICKHOFF W MARK
17 granted patents·4 pending applications·2,290 citations·filing 1994–2025
96Inventor score
Files withMERCK SHARP & DOHME LLC5MERCK SHARP & DOHME4NANO SYS LLC3EASTMAN KODAK CO2ELAN PHARMA INT LTD2
Top patents by PatentIndex Score
21 records- 0197US6432381B2Methods for targeting drug delivery to the upper and/or lower gastrointestinal tractELAN PHARMA INT LTD·Filed 1997·Granted Aug 13, 2002·214 cites·27 claims
- 0297US5580579ASite-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymersNANO SYS LLC·Filed 1995·Granted Dec 3, 1996·357 cites·15 claims
- 0396US12220408B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Feb 11, 2025·5 cites·30 claims
- 0496US12168004B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted Dec 17, 2024·5 cites·30 claims
- 0596US11925709B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2020·Granted Mar 12, 2024·12 cites·10 claims
- 0696US5628981AFormulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agentsNANO SYS LLC·Filed 1994·Granted May 13, 1997·172 cites·10 claims
- 0796US5585108AFormulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable claysNANOSYSTEMS LLC·Filed 1994·Granted Dec 17, 1996·244 cites·4 claims
- 0895US12310953B2Pharmaceutical formulations for the treatment of migraineMERCK SHARP & DOHME LLC·Filed 2024·Granted May 27, 2025·3 cites·30 claims
- 0995US5571536AFormulations of compounds as nanoparticulate dispersions in digestible oils or fatty acidsNANO SYS LLC·Filed 1995·Granted Nov 5, 1996·237 cites·3 claims
- 1095US5560931AFormulations of compounds as nanoparticulate dispersions in digestible oils or fatty acidsNAWOSYSTEMS L L C·Filed 1995·Granted Oct 1, 1996·272 cites·6 claims
- 1195US5518738ANanoparticulate nsaid compositionsNANOSYSTEM LLC·Filed 1995·Granted May 21, 1996·331 cites·15 claims
- 1294US5466440AFormulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable claysEASTMAN KODAK CO·Filed 1994·Granted Nov 14, 1995·155 cites·8 claims
- 1393US5593657ABarium salt formulations stabilized by non-ionic and anionic stabilizersNANOSYSTEMS LLC·Filed 1995·Granted Jan 14, 1997·161 cites·22 claims
- 1492US10117836B2Tablet formulation for CGRP active compoundsMERCK SHARP & DOHME·Filed 2015·Granted Nov 6, 2018·15 cites·21 claims
- 1588US5503723AIsolation of ultra small particlesEASTMAN KODAK CO·Filed 1995·Granted Apr 2, 1996·107 cites·7 claims
- 1688US2025064788A1Treatment of migraineALLERGAN PHARMACEUTICALS INT LTD·Filed 2024·Application pending·0 cites
- 1779US2023248655A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2023·Application pending·0 cites
- 1878US12458633B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·32 claims
- 1977US12458632B2Treatment of migraineMERCK SHARP & DOHME LLC·Filed 2025·Granted Nov 4, 2025·0 cites·29 claims
- 2059US2019209478A1Tablet formulation for cgrp active compoundsMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 2159US2003054045A1Formulations for therapeutic agents absorbed through mucous membranesELAN PHARMA INT LTD·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when W. Mark Eickhoff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →